Jazz breaks ground on $100m UK plant for cannabinoid drugs
pharmaphorum
MARCH 25, 2022
Jazz Pharma has started construction of a manufacturing facility in the UK that will be used to manufacture cannabinoid drugs from its recently acquired GW Pharma subsidiary. The new plant adds to Jazz’s existing presence at KSP, where it employs around 400 staff across 12 buildings.
98 
Let's personalize your content